東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Prevalence and Screening of High Liver Stiffness and Alcohol Associated Fatty Liver Disease : = A Nationally Representative Analysis and Strategy.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Prevalence and Screening of High Liver Stiffness and Alcohol Associated Fatty Liver Disease :/
Reminder of title:	A Nationally Representative Analysis and Strategy.
Author:	Niezen, Sebastian.
Description:	1 online resource (37 pages)
Notes:	Source: Masters Abstracts International, Volume: 83-11.
Contained By:	Masters Abstracts International83-11.
Subject:	Medicine. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29206213click for full text (PQDT)
ISBN:	9798438748137

Prevalence and Screening of High Liver Stiffness and Alcohol Associated Fatty Liver Disease : = A Nationally Representative Analysis and Strategy.
Niezen, Sebastian.

Prevalence and Screening of High Liver Stiffness and Alcohol Associated Fatty Liver Disease :A Nationally Representative Analysis and Strategy. - 1 online resource (37 pages)

Source: Masters Abstracts International, Volume: 83-11.

Thesis (M.Med.Sc.)--Harvard Medical School, 2022.

Includes bibliographical references

Chronic liver disease (CLD) is a major healthcare burden for the United States, responsible for 60,000 deaths annually and recently surpassing heart failure hospitalization rates. We analyzed 4,510 adults sampled by the National Health and Nutrition Examination Survey (NHANES) in the cycle of 2017-2018 who underwent non- invasive vibration-controlled transient elastography (VCTE). Participants are enrolled using a stratified multistage probability with an oversampling design that allows a weighted and simplified representation of the civilian US population.In the first paper, we intended to examine the national estimated prevalence of increased liver stiffness (LSM) measured by VCTE among these participants to characterize the at-risk population. Once the proportion and phenotype were identified, we constructed a screening score based on the variables associated with increased liver stiffness and advanced cirrhosis. The score was validated by calculating C- statistics and compared to the recommended screening FIB-4 score.VCTE data from the same cohort provided controlled attenuation parameter (CAP), which measures hepatic steatosis.Alcohol-associated liver disease (ALD) is responsible for rising rates of cirrhosis and liver-related mortality in the US. It is also one of the most common causes of fatty liver disease (FLD), which is the major contributor of CLD. Considering the lack of evidence on the mechanism and the quantity of alcohol that contributes to fatty liver disease progression, we performed multiple regression models in the second paper using dietary recall to identify the associations between the multiple consumption dimensions and the type of alcohol consumed with hepatic steatosis.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798438748137Subjects--Topical Terms:

641104
Medicine.
Subjects--Index Terms:

AlcoholIndex Terms--Genre/Form:

542853
Electronic books.

Prevalence and Screening of High Liver Stiffness and Alcohol Associated Fatty Liver Disease : = A Nationally Representative Analysis and Strategy.
LDR:03124nmm a2200385K 4500 001 2359766
005 20230917195240.5
006 m o d
007 cr mn ---uuuuu
008 241011s2022 xx obm 000 0 eng d
020 $a 9798438748137
035 $a (MiAaPQ)AAI29206213
035 $a AAI29206213
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Niezen, Sebastian. $3 3700382
245 1 0 $a Prevalence and Screening of High Liver Stiffness and Alcohol Associated Fatty Liver Disease : $b A Nationally Representative Analysis and Strategy.
264 0 $c 2022
300 $a 1 online resource (37 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Masters Abstracts International, Volume: 83-11.
500 $a Advisor: Adam, Rosalyn.
502 $a Thesis (M.Med.Sc.)--Harvard Medical School, 2022.
504 $a Includes bibliographical references
520 $a Chronic liver disease (CLD) is a major healthcare burden for the United States, responsible for 60,000 deaths annually and recently surpassing heart failure hospitalization rates. We analyzed 4,510 adults sampled by the National Health and Nutrition Examination Survey (NHANES) in the cycle of 2017-2018 who underwent non- invasive vibration-controlled transient elastography (VCTE). Participants are enrolled using a stratified multistage probability with an oversampling design that allows a weighted and simplified representation of the civilian US population.In the first paper, we intended to examine the national estimated prevalence of increased liver stiffness (LSM) measured by VCTE among these participants to characterize the at-risk population. Once the proportion and phenotype were identified, we constructed a screening score based on the variables associated with increased liver stiffness and advanced cirrhosis. The score was validated by calculating C- statistics and compared to the recommended screening FIB-4 score.VCTE data from the same cohort provided controlled attenuation parameter (CAP), which measures hepatic steatosis.Alcohol-associated liver disease (ALD) is responsible for rising rates of cirrhosis and liver-related mortality in the US. It is also one of the most common causes of fatty liver disease (FLD), which is the major contributor of CLD. Considering the lack of evidence on the mechanism and the quantity of alcohol that contributes to fatty liver disease progression, we performed multiple regression models in the second paper using dietary recall to identify the associations between the multiple consumption dimensions and the type of alcohol consumed with hepatic steatosis.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Medicine. $3 641104
653 $a Alcohol
653 $a Chronic liver disease
653 $a Liver fibrosis screening
653 $a MMSCI
653 $a NHANES
653 $a Transient elasotgraphy
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0564
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a Harvard Medical School. $b Graduate Education. $3 3691726
773 0 $t Masters Abstracts International $g 83-11.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29206213 $z click for full text (PQDT)